Loading…
← CockpitCompetitor Analysis › 603360.SS Dalian Bio-Chem Co., Ltd. Class AOpen in the cockpit ↗

Dalian Bio-Chem Co., Ltd. Class A603360.SSCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Major Diversified

Dalian-based biochemical company; specific product line not established from available knowledge.

Momentum laggard 3
Mkt cap
$1.05B
US dollars, full cap
Free float
41%
of shares outstanding
$/day
$20.0M
20-day average traded
Fwd P/E
23.5×
forward earnings
ROIC−WACC
+2.4 pp
WACC 5.7%
Hurdle
-9 pp
Req g minus delivered
Next earnings
168 days
23 Apr 2027
Close · CNYCN¥10.11
1D-3.5%
1W+0.2%
1M-17.1%
3M-21.3%
6M-55.4%
YTD-68.6%
1Y-63.7%
ATR %5.7%
52w lowhigh74.1% off high

What Dalian Bio-Chem does

Dalian-based biochemical company; specific product line not established from available knowledge.

Where it sits in the supply chain

  • Materials

Moat: none

Headquarters: Dalian, China · Employees: 1,053

Dalian Bio-Chem at a glance

Size Dalian Bio-Chem (603360.SS) is a China Materials company (Chemicals: Major Diversified) with a market value of $1.05B, the 2202nd largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥10.11 on 6 Nov 2026.

Performance Over six months the shares fell 55.4%, against -30.1% for the median peer and -16.4% for the China market (cap-weighted) — 2nd lowest of 21 in its peer set.

Growth Revenue grew 0.4% over the last twelve months (peer median +2.9%); the operating margin is 16.2% (peer median 12.3%).

Valuation It trades at 23.5× forward earnings against a peer median of 19.2× (3rd most expensive of 14).

Price implies For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -9 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.4 points above its cost of capital (5.7% WACC).

Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).

Relative performance

507510012511 May 202611 Aug 20266 Nov 2026Peer median 70603360.SS 46
Six months, rebased to 100: Dalian Bio-Chem against the median of its 20 peers (local-currency closes).

Dalian Bio-Chem financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.48BCN¥1.72BCN¥1.26BCN¥1.05BCN¥1.24B
Revenue growth—+36%+20%-15%—
Gross profitCN¥611MCN¥598MCN¥542MCN¥529MCN¥638M
EBITDAn/aCN¥473MCN¥429MCN¥427MCN¥517M
Net incomeCN¥146MCN¥210MCN¥392MCN¥328MCN¥403M
Free cash flowCN¥167MCN¥510MCN¥89.0MCN¥323MCN¥347M
Capital expenditureCN¥118MCN¥36.7MCN¥74.9MCN¥67.4MCN¥134M
Total debtCN¥1.33BCN¥1.38BCN¥608MCN¥180MCN¥129M

Quarterly statements and history in the cockpit →

Dalian Bio-Chem competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%VCT214370300641JUBLINGREA60318140416032816003283009104763688359LXS301393RPEL0146806886694471301090457190603360.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Dalian Bio-Chem is the large dot.

Fundamentals: revenue growth against valuation

-40%-20%0%+20%+40%0×100×200×VCT214370JUBLINGREA60318140416032814763301393014680605366603360.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Dalian Bio-Chem is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-20%0%20%40%VCT214370300641JUBLINGREA40416032813009104763LXS6886694471301090603360.SSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Dalian Bio-Chem is the large dot.

Dalian Bio-Chem competitors and peer comparison

How Dalian Bio-Chem compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Dalian Bio-Chem against its 20 peers (data as of 6 Nov 2026)
Measure603360.SSPeer medianRank in peer set
1-month return-17.1%-12.1%8th lowest of 21
6-month return-55.4%-30.1%2nd lowest of 21
Distance from 52-week high-74.1%-45.0%2nd lowest of 21
Revenue growth (TTM)+0.4%+2.9%10th lowest of 21
Operating margin16.2%12.3%9th highest of 21
Forward P/E23.5×19.2×3rd most expensive of 14
Growth the price implies (Req g, 7 yrs)9.5%8.8%7th most demanding of 14
Growth delivered (Del g)+18.4%+6.3%4th highest of 14
Hurdle (Req g minus delivered)-8.8 pp-1.5 pp4th least demanding of 14
ROIC minus cost of capital+2.4 pp-2.1 pp6th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Dalian Bio-Chem 603360.SSChina$1.05B-55%0%16%23.5×9.5%+18.4%
Victrex VCT.LUnited Kingdom$1.04B+54%-1%14%21.7×15.7%+1.9%
Caregen 214370.KSSouth Korea$1.01B-73%-8%24%22.6×35.2%+3.8%
Jiangsu Zhengdan Chemical Industry 300641.SZChina$981M-28%-30%17%n/a8.8%+11.6%
Jubilant Ingrevia JUBLINGREA.NSIndia$966M-24%+15%10%21.1×27.3%+44.9%
Zhejiang Huangma Technology 603181.SSChina$935M-30%+7%17%14.5×n/an/a
Nippon Soda 4041.TJapan$1.19B-5%-1%10%11.1×3.5%+1.8%
Hubei Jianghan New Materials 603281.SSChina$1.20B-30%+8%17%20.5×4.8%+6.3%
CNSIG Inner Mongolia Chemical Industry 600328.SSChina$1.21B-32%-20%-7%n/an/an/a
Xinxiang Richful Lube Additive 300910.SZChina$1.26B-38%+12%16%11.6×0.6%+32.5%
Jinan Acetate Chemical 4763.TWTaiwan$1.26B-3%-36%46%7.3×-17.4%+41.2%
Guangzhou Sanfu Newmaterials Technology 688359.SSChina$870M-41%+8%-7%n/an/an/a
Lanxess LXS.DEGermany$1.27B-30%-10%-1%n/a17.9%-1.5%
Suzhou Highfine Biotech 301393.SZChina$865M-8%+36%17%32.3×n/an/a
Raghav Productivity Enhancers RPEL.NSIndia$864M+133%+38%28%n/an/an/a
Hanchem 014680.KSSouth Korea$1.30B-40%+15%17%11.1×4.7%+7.4%
Polyrocks Chemical 688669.SSChina$831M+40%-8%-6%n/a35.9%+15.2%
Sanyo Chemical Industries 4471.TJapan$823M+24%0%10%10.5×-5.1%-2.5%
Jiangxi Hungpai New Material 605366.SSChina$821M-47%+2%-11%236.0×n/an/a
China Resources Chemical Innovative Materials 301090.SZChina$1.35B-33%+4%1%19.2×21.4%+1.1%
Isuspecialtychemical 457190.KSSouth Korea$1.36B-49%+14%3%n/an/an/a

Questions

Which companies are Dalian Bio-Chem's closest peers?
The cockpit's peer set: Victrex (VCT.L), Caregen (214370.KS), Jiangsu Zhengdan Chemical Industry (300641.SZ), Jubilant Ingrevia (JUBLINGREA.NS), Zhejiang Huangma Technology (603181.SS), Nippon Soda (4041.T), Hubei Jianghan New Materials (603281.SS), CNSIG Inner Mongolia Chemical Industry (600328.SS).
Is Dalian Bio-Chem expensive compared with its peers?
On forward p/e it trades at 23.5× against a peer median of 19.2×, 3rd most expensive of 14 in its peer set. For today's price to make sense, revenue must grow about 10% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -9 pp: the price already allows for a slowdown.
How has Dalian Bio-Chem stock performed?
Over six months to 6 Nov 2026 the shares returned -55.4% against -30.1% for the median peer; over one year -63.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.